An investigational extended-release formulation of minoxidil appears to result in more hair growth in a small phase 2 trial comparing it with immediate-release oral and topical formulations.

AI shifts from promise to practice when customization becomes routine. That is a positive sign. When technical teams work with data as it is, measure progress with discipline, and focus on workflows ...

Fintel reports that on September 29, 2025, Stephens & Co. initiated coverage of Vertex (NasdaqGM:VERX) with a Overweight ...

Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...